Tranilast, an Antifibrogenic Agent, Ameliorates a Dietary Rat Model of Nonalcoholic Steatohepatitis

Hepatology - United States
doi 10.1002/hep.22338
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nonalcoholic Steatohepatitis

English

Pathophysiology of Nonalcoholic Steatohepatitis

Juntendo Medical Journal
2017English

Antifibrotic Effect of Pirfenidone in a Mouse Model of Human Nonalcoholic Steatohepatitis

Scientific Reports
Multidisciplinary
2017English

Farnesoid X Receptor Agonist INT-767 Attenuates Liver Steatosis and Inflammation in Rat Model of Nonalcoholic Steatohepatitis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Comprehensive Circular RNA Expression Profiles in a Mouse Model of Nonalcoholic Steatohepatitis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Lycopene Prevents Development of Steatohepatitis in Experimental Nonalcoholic Steatohepatitis Model Induced by High-Fat Diet

Veterinary Medicine International
Veterinary
2010English

The Epidemiology of Nonalcoholic Steatohepatitis

Clinical Liver Disease
Hepatology
2018English

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Development of Nonalcoholic Steatohepatitis in a Rodent Model

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2015English

Gut Microbiota and Nonalcoholic Steatohepatitis

Folia Pharmacologica Japonica
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy